Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial

NAPOLI-1 Study Group

Research output: Contribution to journalArticle

403 Citations (Scopus)

Fingerprint Dive into the research topics of 'Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences